Abstract
COVID 19 is caused by Severe Acute Respiratory Syndrome Corona Virus-2 which results in wide range of manifestations. Systemic hypercoagulation is a typical feature of COVID-19. We present a case of COVID-19 in whom TEG was performed on admission and hypercoagulability was diagnosed and hence patient was started on Enoxaparin sodium 6000 IU twice daily. TEG was repeated after 5 days which showed normal coagulation status and the patient was discharged without any thrombotic complications.
Original language | English |
---|---|
Pages (from-to) | 148-149 |
Number of pages | 2 |
Journal | Asian Journal of Transfusion Science |
Volume | 16 |
Issue number | 1 |
DOIs | |
Publication status | Published - 01-01-2022 |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Hematology